INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7 | -94.5% | 19,313 | -93.2% | 0.00% | -100.0% |
| Q2 2023 | $127 | -99.9% | 285,122 | +841.0% | 0.00% | 0.0% |
| Q4 2021 | $151,000 | -60.6% | 30,300 | -43.4% | 0.00% | -50.0% |
| Q3 2021 | $383,000 | -45.1% | 53,560 | -28.9% | 0.00% | -66.7% |
| Q2 2021 | $697,000 | +97.5% | 75,292 | -29.8% | 0.01% | -60.0% |
| Q4 2019 | $353,000 | +178.0% | 107,238 | +586.3% | 0.02% | -75.0% |
| Q2 2015 | $127,000 | – | 15,626 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |